본문 바로가기
KERD
논문KCI 등재

Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: To evaluate the enhancement patterns of liver metastases and their influencing factors using dynamic contrast-enhanced ultrasound (CEUS). Methods: A total of 240 patients (139 male and 101 female; 58.5±11.2 years of age) diagnosed with liver metastases in our hospital were enrolled in this study to evaluate tumor characteristics using CEUS. A comparison of enhancement patterns with tumor size and primary tumor type was performed using the chi-square test. The differences between quantitative variables were evaluated with the independent-sample t-test and one-way analysis of variance. Results: The enhancement patterns of liver metastases on CEUS were categorized as diffuse homogeneous hyperenhancement (133/240, 55.4%), rim-like hyperenhancement (80/240, 33.3%), heterogeneous hyperenhancement (10/240, 4.2%), and isoenhancement (17/240, 7.1%). There were significant differences in the enhancement patterns during the arterial phase based on the nodule size (p=0.001). A total of 231 of the nodules showed complete washout during the portal phase, and 237 nodules were hypoenhanced during the delayed phase. The washout time was correlated with tumor vascularity, with a longer washout time observed in hypervascular metastases compared to hypovascular metastases (p=0.033). Conclusions: Diffuse homogeneous hyperenhancement followed by rapid washout was the most common enhancement pattern of liver metastases on CEUS and was affected by the nodule size and tumor vascularity. Small metastases were prone to show diffuse homogeneous hyperenhancement. Hypervascular metastases showed a significantly longer washout time compared to hypovascular metastases.

Abstract

Background/Aims: To evaluate the enhancement patterns of liver metastases and their influencing factors using dynamic contrast-enhanced ultrasound (CEUS). Methods: A total of 240 patients (139 male and 101 female; 58.5±11.2 years of age) diagnosed with liver metastases in our hospital were enrolled in this study to evaluate tumor characteristics using CEUS. A comparison of enhancement patterns with tumor size and primary tumor type was performed using the chi-square test. The differences between quantitative variables were evaluated with the independent-sample t-test and one-way analysis of variance. Results: The enhancement patterns of liver metastases on CEUS were categorized as diffuse homogeneous hyperenhancement (133/240, 55.4%), rim-like hyperenhancement (80/240, 33.3%), heterogeneous hyperenhancement (10/240, 4.2%), and isoenhancement (17/240, 7.1%). There were significant differences in the enhancement patterns during the arterial phase based on the nodule size (p=0.001). A total of 231 of the nodules showed complete washout during the portal phase, and 237 nodules were hypoenhanced during the delayed phase. The washout time was correlated with tumor vascularity, with a longer washout time observed in hypervascular metastases compared to hypovascular metastases (p=0.033). Conclusions: Diffuse homogeneous hyperenhancement followed by rapid washout was the most common enhancement pattern of liver metastases on CEUS and was affected by the nodule size and tumor vascularity. Small metastases were prone to show diffuse homogeneous hyperenhancement. Hypervascular metastases showed a significantly longer washout time compared to hypovascular metastases.

참고문헌 (15)

  1. Wernecke K, "Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging", AJR Am J Roentgenol, 157, pp.731~739 (1991)
  2. Dietrich CF, "Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI", World J Gastroenterol, 12, pp.1699~1705 (2006)
  3. Piscaglia F, "Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer", BMC Cancer, 7, pp.171~ (2007)
  4. Correas JM, "Contrast enhanced ultrasound in the detection of liver metastases: a prospective multicentre dose testing study using a perfluorobutane microbubble contrast agent (NC100100)", Eur Radiol, 21, pp.1739~1746 (2011)
  5. Sugimoto K, "Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis", Acad Radiol, 16, pp.798~809 (2009)
  6. Claudon M, "Guidelines and good clinical practice recommendations for contrast enhanced ultrasound", Ultraschall Med, 29, pp.28~44 (2008)
  7. Dănilă M, "Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases", Med Ultrason, 12, pp.233~237 (2010)
  8. Claudon M, "Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS", Ultrasound Med Biol, 39, pp.187~210 (2013)
  9. Murphy-Lavallee J, "Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography", J Ultrasound Med, 26, pp.1545~1556 (2007)
  10. Kanematsu M, "Imaging liver metastases:review and update", Eur J Radiol, 58, pp.217~228 (2006)
  11. Loria F, "Contrastenhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy", Updates Surg, 64, pp.247~255 (2012)
  12. Kong WT, "Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound", J Gastroenterol Hepatol, 29, pp.576~580 (2014)
  13. Cosgrove D, "Liver tumors: evaluation with contrastenhanced ultrasound", Abdom Imaging, 29, pp.446~454 (2004)
  14. Larsen LP, "Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: a review", World J Hepatol, 2, pp.8~15 (2010)
  15. Mörk H, "Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography", Scand J Gastroenterol, 42, pp.652~662 (2007)

관련 논문AI추천

Clinically Useful Diagnostic Tool of Contrast Enhanced Ultrasonography for Focal Liver Masses: Comparison to Computed Tomography and Magnetic Resonance Imaging김부성, 김상균, 김영석, 김지혜, 김진녕, 김홍수, 류성우, 박의주, 복진현, 심광연, 이세환, 이웅철, 장재영, 정승원, 조영덕, 차상우, 함남석거트앤리버 소화기연관학회협의회 · Gut and Liver2014 · 제8권 제3호Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma김부성, 김상균, 김영석, 김용재, 김홍수, 박길효, 이세환, 장재영, 정승원, 조영덕, 차상우, Soon Ha Kwon, Yong Sub Lee대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제2호A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions김명진, 박미숙, 서니은, 안찬식, 이진영, 한경화, Gulbahor Rakhmonova대한간학회 · Clinical and Molecular Hepatology2017 · 제23권 제1호The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study권상옥, 김문영, 김영주, 박소연, 백순구, 조윤주, 차승환, 최은희대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제2호Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound이정민, Jeong Hee Yoon, Junghoan Park, Tae-Hyung Kim대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US강태욱, 민지혜, 송경두, 이민우, 임상혁, 임현철, 임효근, 최서연대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제1호

이 간행물의 다른 논문 (21건)